Cargando…
Semapimod Sensitizes Glioblastoma Tumors to Ionizing Radiation by Targeting Microglia
Glioblastoma is the most malignant and lethal form of astrocytoma, with patients having a median survival time of approximately 15 months with current therapeutic modalities. It is therefore important to identify novel therapeutics. There is mounting evidence that microglia (specialized brain-reside...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015930/ https://www.ncbi.nlm.nih.gov/pubmed/24816734 http://dx.doi.org/10.1371/journal.pone.0095885 |